- Report
- November 2025
- 132 Pages
Global
From €839EUR$950USD£734GBP
- Report
- June 2025
- 119 Pages
Brazil
From €5294EUR$5,995USD£4,631GBP
- Report
- June 2025
- 119 Pages
Mexico
From €5294EUR$5,995USD£4,631GBP
- Report
- June 2025
- 124 Pages
Japan
From €5294EUR$5,995USD£4,631GBP
- Report
- June 2025
- 132 Pages
China
From €5294EUR$5,995USD£4,631GBP
- Report
- June 2025
- 119 Pages
Russia
From €5294EUR$5,995USD£4,631GBP
- Report
- June 2025
- 122 Pages
Spain
From €5294EUR$5,995USD£4,631GBP
- Report
- October 2024
- 70 Pages
Global
From €839EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
North America
From €839EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €839EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Europe
From €839EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Japan
From €839EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
United States
From €839EUR$950USD£734GBP
- Report
- March 2024
- 132 Pages
Global
From €839EUR$950USD£734GBP
- Report
- February 2024
- 132 Pages
Global
From €839EUR$950USD£734GBP
- Report
- June 2023
- 36 Pages
South Korea
From €3528EUR$3,995USD£3,086GBP
- Report
- June 2023
- 36 Pages
China
From €3528EUR$3,995USD£3,086GBP
- Report
- June 2023
- 34 Pages
Russia
From €3528EUR$3,995USD£3,086GBP
- Report
- June 2023
- 35 Pages
Spain
From €3528EUR$3,995USD£3,086GBP
- Report
- June 2023
- 33 Pages
France
From €3528EUR$3,995USD£3,086GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more